Uncategorized


September 18, 2026

[PNTG, BTSG, AVAH, ADUS] Home Health Comment Review Reinforces Medicare Stable Outlook and Suggests Paths for Upside

By Beth Steindecker

Based on our review of stakeholder comments to CMS’s proposed CY27 Medicare home health (HH) payment rule, we continue to see an avenue for HH-specific upside in the final regulation due in late October/early November…

Read More >>

September 16, 2026

AI Legislation: Congress Has No Clear Path on Frontier-Model Testing

By Joe Lieber

We continue to believe that Congress is unlikely to enact any material AI legislation this year (and maybe not through 2028) due to opposition from President Trump and more importantly, lacking consensus on what Congress…

Read More >>

September 14, 2026

Capitol Policy Weekly: Crypto, AI and Russia Sanctions Before the Recess

By Joe Lieber

Both the House and Senate are in session this week, but this is the last week the lower chamber is expected to be in Washington before the midterm elections. The Senate is supposed to be…

Read More >>

September 14, 2026

[HCA, THC, DVA, PRVA, ENSG, PNTG]: Mapping Provider Policy Risk / Upside by Congressional Control in November Elections

By Beth Steindecker

With the November elections less than two months away, we assess how different congressional outcomes could reshape the healthcare legislative agenda for hospitals, dialysis centers, value-based care (VBC) providers, skilled nursing facilities (SNFs), post-acute care…

Read More >>

September 11, 2026

EW: Asymptomatic Wins & Moderate AS Misses

By John Leppard

CMS’s finalized national coverage determination (NCD) last night should support an incremental ~120 bps in growth for EW’s TAVR franchise in 2027, with the agency largely codifying the criteria initially outlined in its June proposal….

Read More >>

September 9, 2026

2026 Senate Elections: Democrats’ Progress

By Joe Lieber

We believe control of the Senate is a toss-up, although, if forced to choose, we give Republicans a slight edge in retaining control of the upper chamber. We continue to think Democrats are very likely…

Read More >>

September 8, 2026

[CNC, OSCR, UNH, HUM, CVS, ELV, MOH, CI, HQY]: Mapping Payer Policy Risk / Upside by Congressional Control in November Elections

By Beth Steindecker

With the November elections less than two months away, we assess how different congressional outcomes could reshape the healthcare legislative agenda for health insurers, pharmacy benefit managers (PBMs), 340B contract pharmacies, and health savings account…

Read More >>

September 2, 2026

EW: TAVR NCD Expectations & Implications

By John Leppard

With CMS set to release its finalized update to the TAVR NCD by Sept. 13 [likely posted after the close here], we largely expect it to maintain the core elements of the original proposal. More…

Read More >>

September 1, 2026

[DVA, FRE.DE, private US Renal] Final CY27 Dialysis Reg Likely Similar to Proposal; Limited, but Plausible, Paths to Upside

By Beth Steindecker

Our review of stakeholder feedback on CMS’s CY27 Medicare payment rule for dialysis centers [DVA, FRE.DE, private US Renal Care and Innovative Renal Care] leaves us expecting a final rule similar to the June proposal,…

Read More >>

August 31, 2026

Capitol Policy Weekly: Government Funding and Legislative Outlook

By Joe Lieber

The House is in session this week but will be out next week for the Labor Day district work period. The Senate will not return until the week of September 14. In addition to looking…

Read More >>